Diagnostic accuracy of self-collected human papillomavirus specimens as a primary screen for cervical cancer

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 8, 2012, Pages 795-799

  Quincy, B L ^a   Turbow, D J ^b   Dabinett, L N ^c   Dillingham, R ^d   Monroe, S ^d  

^a ELON UNIVERSITY   (United States)

^b Trident University International   (United States)

^c Women's Center of Winchester   (United States)

^d Winchester Medical Center   (United States)

Author keywords

Cervical cancer; Human papillomavirus; Self collection; Sensitivity

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICIAL COLLECTION; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NICARAGUA; PELVIC EXAMINATION; PHYSICIAN; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF COLLECTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VAGINA; VAGINA CYTOLOGY; WART VIRUS;

ADULT; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; NICARAGUA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SELF CARE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 84867701036     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2012.717989     Document Type: Article

References (31)

1. Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C et al. 2010. Accuracy and cost-effectiveness of cervical cancer screening by high-risk DNA testing of self-collected vaginal samples. Journal of Lower Genital Tract Disease 143: 185-195.
2. Buechler EJ. 2005. Pap tests and HPV infection. Postgraduate Medicine 118: 37-43.
3. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G et al. 2007. Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization 85: 719-227.
4. DeAlba I, Anton-Culver H, Hubbell A, Ziogas A, Hess JR, Bracho A et al. 2008. Self-sampling for human papillomavirus in a community setting: Feasibility in Hispanic women. Cancer Epidemiology Biomarkers and Prevention 17: 2163-2168.
5. Dzuba IG, Diaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV et al. 2002. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. Journal of Women' s Health and Gender-based Medicine 11: 265-274.
6. Flores Y, Bishai D, Lazcano E, Shah K, Lorincz A, Hernandez M et al. 2003. Improving cervical cancer screening in Mexico: Results from the Morelos HPV study. Salud Publica Mexicana 45: S388-S398.
7. Flores Y, Shah K, Lazcano EC, Hern á ndez M, Bishai D, Ferris D et al. 2002. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study. Salud Publica Mexicana 44: 335-344.
8. Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Korneguay JR et al. 2001. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology, Biomarkers and Prevention 10: 95-100.
9. Holanda F, Castelo A, Veras TMCW, de Almeida FML, Lins MZ, Dores GB. 2006. Primary screening for cervical cancer through self sampling. International Journal of Gynecology and Obstetrics 95: 179-184.
10. Kahn JA, Bernstein DI, Rosenthal SL, Huang B, Kollar LM, Colyer JL et al. 2005. Acceptability of human papillomavirus self testing in female adolescents. Sexually Transmitted Infections 81: 408-414.
11. Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C et al. 2007. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. International Journal of Gynecologic Cancer 17: 615-622.
12. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. Journal of the National Cancer Institute 92: 818-825.
13. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM et al. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. Journal of the American Medical Association 288: 1749-1757.
14. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang Y et al. 2002. Benefits and costs of using HPV testing to screen for cervical cancer . Journal of the American Medical Association 287: 2372-2381.
15. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ. 1999. Identifying women withcervical neoplasia: Using human papillomavirus testing for equivocal Papanicolaou results. Journal of the American Medical Association 281: 1605-1610.
16. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A et al. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal Medicine 357: 1579-1588.
17. PAHO. 2008. Regional strategy and plan of action for cervical cancer prevention and control. Washington DC: Pan American Health Organization. Available at: www.paho.org/english/gov/cd/cd48-org/english/gov/cd/06-e.pdf (Accessed 2 May 2009).
18. Quincy BL, Turbow DJ, Dabinett LN. 2012. Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer. Journal of Obstetrics and Gynaecology 32: 87-91.
19. Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M et al. 2007. Comparability of self-collected vaginal swabs and physiciancollected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sexually Transmitted Diseases 34: 429-436.
20. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A et al. 2003. Comparison of HPV-based assays withPapanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14: 505-512.
21. Sankaranarayanan R, Nene B, Shastri SS, Jayant K, Muwonge R, Budukh AM et al. 2009. HPV screening for cervical cancer in rural India. New England Journal of Medicine 360: 1385-1394.
22. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S et al. 2000. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. Journal of the American Medical Association 283: 87-93.
23. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P et al. 2000. Comparison of self-collected vaginal, vulvar and urine samples withphysician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Canadian Medical Association Journal 163: 513-518.
24. Stenvall H, Wikstrom I, Backlund I, Wilander E. 2007. Accuracy of HPV testing of vaginal smear obtained witha novel self-sampling device. Acta Obstetricia et Gynecologica Scandinavica 86: 16-21.
25. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J et al. 2007. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. Journal of Medical Screening 14: 34-42.
26. Taylor S, Kuhn L, Dupree W, Denny L, De Souza M, Wright TC. 2006. Direct comparison of liquid-based and conventional cytology in a Southafrican screening trial. International Journal of Cancer 118: 957-962.
27. WHO. 2007. Cervical cancer, human papillomavirus (HPV), and HPV vaccines: Key points for policy-makers and Health professionals. Geneva: World Health Organization. WHO Document Production Services. Available at: www.who.int/reproductive-Health/publications/cervical-cancer-keypoints/ cerv-cancer-hpv-keypts.pdf (Accessed 2 May 2009).
28. WHO/ICO, Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus. and related cancers in Nicaragua. 2009. Summary Report 2009. Geneva: WHO Document Production Services. Available at: www.who.int/hpvcentre. (Accessed 27 October 2009).
29. Widdice LE, Moscicki AB. 2008. Updated guidelines for Papanicolaou tests, colposcopy and human papillomavirus testing in adolescents. Journal of Adolescent Health 43: S41-S51.
30. Wikstrom I, Stenvall H, Wilander E. 2007. Attitudes to self-sampling of vaginal smear for human papillomavirus analysis among women not attending organized cytological screening. Acta Obstetrica Gynecologica 86: 720-725.
31. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. 2000. HPV DNA testing of self-collected vaginal samples compared withcytologic screening to detect cervical cancer. Journal of the American Medical Association 283: 81-86.